
2027 Future Talent Program - Global Site Agreements - Intern
Merck
Summary
The Future Talent Program features internships that last up to 12 weeks and will include one or more projects. Global Clinical Trial Operations (GCTO) is responsible for planning and executing our company's clinical trials globally. Within GCTO, Global Site Agreements (GSA) supports the agreements, contracting, and legal activities that enable clinical research, with a particular focus on clinical site contracting and related agreement processes.
Job description
GSA is seeking a curious, motivated intern with an interest in technology, contracting, clinical research, and/or process improvement. The intern will collaborate with GSA and GCTO colleagues to understand business challenges, analyze processes and information, identify opportunities for improvement, and develop practical solutions.
Primary Responsibilities
- Partner with GSA and GCTO stakeholders to understand business processes, contracting activities, administrative needs, challenges, pain points, and opportunities for improvement.
- Review, organize, and summarize business, legal, contracting, or operational information to support clear and practical recommendations.
- Support process mapping, requirements gathering, documentation, standardization, and workflow redesign.
- Identify opportunities to reduce manual activities, simplify workflows, improve controls, and strengthen the user experience.
- Contribute to technology-enabled solutions, such as automation, dashboards, reporting, collaboration tools, or artificial intelligence use cases, where appropriate.
- Analyze operational data and information to identify trends, patterns, bottlenecks, risks, and improvement opportunities.
- Assist with agreement-related process reviews, template or guidance updates, issue tracking, records organization, and other legal operations or administrative activities.
- Document and communicate requirements, processes, findings, recommendations, and outcomes for stakeholder and leadership audiences.
Required Qualifications
- Currently enrolled full-time in a BS/BA program or an accredited J.D. program.
- Relevant areas of study may include science, technology, information systems, business/public administration, legal studies, pre-law, or a related discipline.
- Minimum of two years of collegiate study completed by June 2027.
- Available to work full-time for up to 12 weeks beginning May or June 2027.
- Detail-oriented, organized, and able to manage multiple priorities.
- Comfortable working with cross-functional teams and stakeholders across the globe.
- Demonstrated interest in one or more of the following: technology, legal operations, contracting, clinical operations, process improvement, innovation, data, or related disciplines.
- Strong problem-solving skills, intellectual curiosity, sound judgment, and willingness to learn and apply new tools, processes, and concepts.
- Ability to analyze, organize, and synthesize information and translate findings into practical recommendations, documentation, and solutions.
- Strong written and verbal communication skills and the ability to collaborate effectively with colleagues.
Preferred Qualifications
- Coursework, project experience, or hands-on experience in two or more of the following: Legal research, document review, and policy/procedure development.
- Business administration, project management, stakeholder engagement, meeting facilitation, and operational support.
- Process improvement, process mapping, requirements gathering, workflow design, and change management.
- Generative AI tools, such as Microsoft Copilot or Google Gemini.
- Microsoft Power Platform, such as Power BI, Power Automate, or Power Apps.
- Data analysis, reporting, data visualization, and dashboard development.
- Microsoft 365 tools, including Excel, PowerPoint, Word, Teams, and SharePoint.
- Clinical research, regulated environments, and global business processes.
Requirements
- Currently enrolled full-time in a BS/BA program or an accredited J.D. program
- Relevant areas of study may include science, technology, information systems, business/public administration, legal studies, pre-law, or a related discipline
- Minimum of two years of collegiate study completed by June 2027
- Available to work full-time for up to 12 weeks beginning May or June 2027
- Detail-oriented, organized, and able to manage multiple priorities
- Comfortable working with cross-functional teams and stakeholders across the globe
- Demonstrated interest in technology, legal operations, contracting, clinical operations, process improvement, innovation, data, or related disciplines
- Strong problem-solving skills, intellectual curiosity, sound judgment, and willingness to learn and apply new tools, processes, and concepts
- Ability to analyze, organize, and synthesize information and translate findings into practical recommendations, documentation, and solutions
- Strong written and verbal communication skills and the ability to collaborate effectively with colleagues
Benefits
- Hybrid Work Arrangement
- No Relocation
- No Travel Required
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.